山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (3): 76-80.doi: 10.6040/j.issn.1673-3770.0.2015.154

• 论著 • 上一篇    下一篇

下调血管内皮细胞蛋白激酶CK2表达对血管增殖影响的体外研究

杜祥阁1, 张营春2, 颜昕2, 王翠2, 赵博军2   

  1. 1. 山东中医药大学第二临床学院, 山东 济南 250014;
    2. 山东大学附属省立医院眼科中心, 山东 济南 250021
  • 收稿日期:2015-04-13 修回日期:2015-05-13 发布日期:2015-06-16
  • 作者简介:杜祥阁。E-mail:duxiangge@126.com

In vitro study of the effect of Casein Kinase2 siRNA on anginogesis

DU Xiangge1, ZHANG Yingchun2, YAN Xin2, WANG Cui2, ZHAO Bojun2   

  1. 1. Second Clinical Medicine College, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, China;
    2. Department of Ophthalmology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2015-04-13 Revised:2015-05-13 Published:2015-06-16
  • Contact: 赵博军。E-mail:zhaobojun@hotmail.com E-mail:zhaobojun@hotmail.com

PDF (PC)

513

摘要： 目的 探究蛋白激酶CK2表达下调对血管内皮细胞形成新生血管的能力以及对其细胞中血管内皮生长因子(VEGF)表达的影响。方法 化学合成siRNA转染人脐静脉内皮细胞(HUVECs), 用RT-PCR法和Western blotting法检测细胞转染效率;MTT法检测CK2表达下调对HUVECs细胞增殖的影响;成管实验和划痕实验检测CK2表达下调对细胞成管、迁移的影响;Real-time PCR和Western blotting法检测siRNA干扰蛋白激酶CK2表达后VEGF mRNA及蛋白的表达。结果 siRNA干扰蛋白激酶CK2达到了预期干扰率75%, 蛋白激酶CK2表达下调后抑制了HUVECs增殖、成管、迁移(P<0.05), 也抑制了VEGF mRNA及蛋白的表达。结论 蛋白激酶CK2表达下调可抑制VEGF的表达及HUVECs的增殖、成管、迁移。

关键词: 蛋白激酶CK2, siRNA, 血管内皮细胞, 视网膜新生血管, 血管内皮生长因子

Abstract: Objective To prove the effect of Casein Kinase2 siRNA on vascular endothelial growth factor(VEGF) expression and the angiogenic capacity in human umbilical vein endothelial cells (HUVECs). Methods HUVECs were transfected with either Casein Kinase2 siRNA or negative control siRNA. Cell proliferation was analyzed by MTT assay; the angiogenic capacity was accessed by tube formation; cell migration was assessed by the wound-healing model. Gene and protein expressions of VEGF were examined by Real-time PCR and Western blotting methods. Results Casein Kinase2 siRNA decreased the expressions of Casein Kinase2 and declined HUVEC proliferation, tube formation and migration. It was also reduced the expression of VEGF mRNA and VEGF protein. Conclusion Our results demonstrated that Casein Kinase2 siRNA reduced the expression of VEGF and declined the capacity of angiogenesis in HUVECs.

Key words: Angiogenesis, Vascular endothelial growth factor, Casein Kinase 2, siRNA, Vascular endothelial cells

中图分类号: 

  • R774.1
[1] Campochiaro P A. Ocular neovascularization[J]. J Mol Med (Berl), 2013, 91(3):311-321.
[2] Dorrell M, Uusitalo-Jarvinen H, Aguilar E, et al. Ocular neovascularization: basic mechanisms and therapeutic advances[J]. Surv Ophthalmol, 2007, 52(1):3-19.
[3] Andrei A. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina[J]. Am J Pathol, 2006, 168(5):1722-1736.
[4] Kramerov A A, Ljubimov A V. Focus on molecules:protein kinase CK2[J]. Exp Eye Res, 2012, 8(101):111-112.
[5] Barnstable C J, Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential[J]. Prog Retin Eye Res, 2004, 23(5):561-577.
[6] Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals mir-199ab-3p as therapeutic target for hepatocellular carcinoma[J].Cancer Cell, 2011, 19(2):232-243.
[7] Ren Shancheng, Liu Yawei. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer[J]. J Urol, 2013, 190(6):2278-2287.
[8] Duncan J S, Litchfield D W. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2[J]. Biochim Biophys Acta, 2008, 1784(1):33-47.
[9] Dorrell M I, Aguilar E, Scheppke L, et al . Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis[J]. Proc Natl Acad Sci USA, 2007, 104(3):967-972.
[10] Maloney S C, Godeiro K D, Odashiro A N, et al. Current and emerging concepts in the management of neovascular age-related macular degeneration[J]. Cardiovasc Hematol Agents Med Chem, 2007, 5(2):147-154.
[11] Ljubimov A V, Caballero S, Aoki A M, et al. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization[J]. Invest Ophthalmol Vis Sci, 2004, 45(12):4583-4591.
[12] Pagano M A, Poletto G, Di Maira G, et al. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors[J]. Chembiochem, 2007, 28(1):129-139.
[13] Golub A G, Yakovenko O Y, Prykhod'ko A O, et al. Evaluation of 4, 5, 6, 7-tetrahalogeno-1H-isoindole-1, 3(2H)-diones as inhibitors of human protein kinase CK2[J]. Biochim Biophys Acta, 2008, 1784(1):143-149.
[14] Zamore P D, Tuschl T, Sharp P A, et al. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals[J]. Cell, 2000, 101(1):25-33.
[1] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[2] 王丽雪,曾毅,王丽欣,彭先兵. 浸润毕罗芬明胶海绵在功能性鼻内镜鼻窦手术后应用效果的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 16-25.
[3] 徐恩沛,孙先勇. 渗出性年龄相关性黄斑变性并发视网膜色素上皮脱离的诊治进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 125-142.
[4] 王露萍,寇芳柠,王皓,张灿伟,王艳玲,尤冉,吴伟珍. 视网膜下高反射物质在抗VEGF治疗nAMD患者中对视力预后的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 101-105.
[5] 李曼冯雪,王艳玲. 眼缺血综合征与缺血性脑卒中相关性研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 88-92.
[6] 樊慧娟，张海利. HIF-1α与VEGF在中耳胆脂瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 93-97.
[7] 刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[8] 李萱, 黄映湘. 25例虹膜新生血管发生原因探讨[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 41-47.
[9] 李浩,李延忠,王岩. HIF-1α、VEGF在阻塞性睡眠呼吸暂停低通气综合征患者[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 43-47.
[10] 王翠,颜昕,赵博军. IVR联合PDT治疗湿性年龄相关性黄斑变性的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 94-97.
[11] 周玮琰,王洪亚,杜秀娟,董卫红. 甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 90-95.
[12] 李兰根, 伟伟, 张玉凤, 格日乐图, 杨佳, 张艳梅. SIRT1抗视网膜色素上皮细胞氧化应激作用的实验研究[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 56-59.
[13] 李盈盈, 周涵, 张伟强, 董伟达. 沉默HIF-1α基因对鼻黏膜上皮细胞生长因子表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 38-42.
[14] 李俊英. 瑞舒伐他汀联合非诺贝特对老年糖尿病视网膜病变患者血管内皮功能的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 72-75.
[15] 张营春, 杜祥阁, 颜昕, 王翠, 赵博军. 尼古丁对人RPE细胞及HUVEC的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 74-80.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发